About Brandon Lieng

This author has not yet filled in any details.
So far Brandon Lieng has created 145 blog entries.

2026122

Sara Abdeljalil Egypt Serum Exosomal LncRNA NAMPT-AS in Breast Cancer: From Molecular Function to Clinical Implications Sara M. Abdeljalil a, Sherehan G. Abdelhamid b, Ramy Ghali c, Montaser B. Yasser d, Mohamed M. Kamal b, e, f, * and Dina H. Kassem b,* a The Environmental Monitoring Center, Central Administration of Environmental Affairs, Ministry [...]

2026121

María Moya Navamuel Panama Natural products as enhancers of tumor antigen presentation and immune sensitivity in colorectal cancer models María Moya-Navamuel1,3, Olga Genilloud2 and Timothy M Thomson1,4 1. Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama City, Panama2. Fundación MEDINA, Granada, Spain 3. Doctoral Program, Department of Biotechnology, Universitat Politècnica de València [...]

2026124

Nermin M. Mohamed Egypt Uncovering the Multifaceted Role of the Kinetochore Scaffold 1 in Hepatocellular Carcinoma: In-Silico Analysis and CRISPR-Cas9 Experimental Study Nermin M. Mohamed1, Rania Hassan Mohamed2, Mahmoud M. Elhefnawi3, Nadia M. Hamdy1 1 Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia 11566, Cairo, Egypt, 2 Biochemistry Department, Faculty of Science, Ain [...]

2026123

Bright Afranie United States Role of hypoxia in coronary angiogenesis: Hypoxia stimulate SOX17-mediated- but repress APJ-mediated-Coronary Angiogenesis in developing mouse heart Bright O. Afranie, Chhiring Sherpa, Bryce Kushal, Alyx Panoncillo, Ken Reed, Felix Addo, Rupak Parajuli, and Bikram Sharma, PhD. 1.Department of Biology, Ball State University, Muncie, IN, USA Abstract Background Coronary Artery Disease [...]

2026106

Obaydah Alabrahim Egypt β-Cyclodextrin Nanoparticles Loaded with Boswellia Extract for Enhanced Antimicrobial and Antibiofilm Activity Obaydah Abd Alkader Alabrahim¹, Mostafa Fytory¹,², Ahmed M. Abou-Shanab³, Jude Lababidi¹, Wolfgang Fritzsche⁴, Nagwa El-Badri³*, Hassan Mohamed El-Said Azzazy¹,⁴* 1. Department of Chemistry, School of Sciences & Engineering, The American University in Cairo, AUC Avenue, P.O. Box 74, New [...]

2026107

Ahmed Kabel Egypt Fraxetin mitigates doxorubicin-induced cardiotoxicity Ahmed M. Kabel1, Samir A. Salama2, Almokhtar A. Adwas3, Aya A. Kabel4, Remon S. Estfanous5 1. Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta 31527, Egypt 2. Division of Biochemistry, Department of Pharmacology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia 3. [...]

2026108

Naledi Pilusa South Africa Fragment screening on S.mansoni glyderaldehyde-3-phosphate dehydrogenase by x-ray crystallography towards the discovery of anti-schistosomal compounds Naledi Pilusa1, Lizbé Koekemoer2, Julia Griese3; Abidemni Paul Kappo1 1Molecular Biophysics and Structural Biology Group, Department of Biochemistry, University of Johannesburg, Johannesburg, South Africa 2Centre for Medicines Discovery, University of Oxford, NDM Research Building, Oxford, Oxfordshire, [...]

2026110

Stella Adom Ghana Comparative Genomic of Infectious Coryza Pathogen Avibacterium Paragallinarum Iris De-baker Dadson1 Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana Abstract Background Avibacterium paragallinarum (A. paragallinarium) is a gram-negative bacterium of the family Pasteurellaceae and the causative agent of infectious coryza (IC), an acute contagious respiratory disease [...]

2026109

Oleksandr Mushii Ukraine MicroRNA-Based Multiple Logistic Regression Models for Predicting Molecular Subtypes of Breast Cancer R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, 45 Vasylkivska St., 03022, Kyiv, Ukraine Abstract Background Molecular classification of breast cancer (BC) is a key element of personalized treatment, as the molecular subtype [...]

2026103

Emmanuel Fajemisin South Africa Antibody Bioconjugates as targeted therapeutics for CD64+ dysfunctional monocytes/macrophages implicated in cancer types. Emmanuel Adebowale Fajemisin 1, Olusiji Alex Akinrinmade 1, 2 , Stefan Barth 1,3. 1 Medical Biotechnology and Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, Universityof Cape Town, Cape Town 7700, [...]

Go to Top